| CAS NO: | 1855925-27-7 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 生物活性 | Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) oncancercells andCD3on T cells. Cibisatamab (CEA-TCB) triggers T cell killing ofcancercell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectalcancerresearch[1]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 1855925-27-7 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com